Ons team van toegewijde artsen en onderzoekers richt zich op het verbeteren van de diagnostiek, behandeling en (na)zorg voor patiënten met sarcomen: een zeldzame vorm van kanker die ontstaat in het bot of zachte weefsel van het lichaam. We zijn trots op onze samenwerking met andere instellingen over de hele wereld en ons wetenschappelijk onderzoek dat sterk verweven is met de klinische zorg. Op deze pagina vindt u een overzicht van onze gepubliceerde artikelen, klinische studies en andere publicaties. We hopen dat deze pagina bijdraagt aan de verdere ontwikkeling van de zorg voor patiënten met sarcomen.
Onze publicaties
Publicatie
Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors – systematic review
Pediatr Radiol. 2018 Feb;48(2):241-252
Smets AM, Deurloo EE, Slager TJE, Stoker J, Bipat S
Publicatie
A patient with scapular Ewing sarcoma; 5-year follow-up after extracorporeal irradiation and re-implantation of the scapula, a case report
J Bone Oncol. 2013 Jan 8;2(1):30-2
Hoornenborg D, Veltman ES, Oldenburger F, Bramer JA, Schaap GR
Publicatie
Participation rates of childhood cancer survivors to self-administered questionnaires: a systematic review
Eur J Cancer Care (Engl). 2017 Nov;26(6)
Kilsdonk E, Wendel E, van Dulmen-den Broeder E, van Leeuwen FE, van den Berg MH, Jaspers MW
Publicatie
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Lancet Oncol. 2016 Oct;17(10):1396-1408 PMID: 27569442
Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS
Publicatie
acial asymmetry in head and neck rhabdomyosarcoma survivors
Pediatr Blood Cancer. 2017 Oct;64(10)
Schoot RA, Hol MLF, Merks JHM, Suttie M, Slater O, van Lennep M, Hopman SMJ, Dunaway D, Syme-Grant J, Smeele LE, Zwinderman KH, Caron HN, Hammond P
Publicatie
Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies
Pediatr Blood Cancer. 2017 Sep;64(9) PMID: 28205365
Rogers T, Minard-Colin V, Cozic N, Jenney M, Merks JHM, Gallego S, Devalck C, Gaze MN, Kelsey A, Oberlin O, Stevens M, Spicer RD, Bergeron C, Martelli H
Publicatie
Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)
Eur J Cancer. 2017 Sep;83:177-184
Chisholm JC, Merks JHM, Casanova M, Bisogno G, Orbach D, Gentet JC, Thomassin-Defachelles AS, Chastagner P, Lowis S, Ronghe M, McHugh K, van Rijn RR, Hilton M, Bachir J, Fürst-Recktenwald S, Geoerger B, Oberlin O
Publicatie
Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)
Eur J Cancer. 2017 Sep;83:177-184
Chisholm JC, Merks JHM, Casanova M, Bisogno G, Orbach D, Gentet JC, Thomassin-Defachelles AS, Chastagner P, Lowis S, Ronghe M, McHugh K, van Rijn RR, Hilton M, Bachir J, Fürst-Recktenwald S, Geoerger B, Oberlin O
Publicatie
Investigating the heterogeneity of alkylating agents’ efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)
Pediatr Blood Cancer. 2017 Aug;64(8) PMID: 28111876
Fresneau B, Hackshaw A, Hawkins DS, Paulussen M, Anderson JR, Judson I, Litière S, Dirksen U, Lewis I, van den Berg H, Gaspar N, Gelderblom H, Whelan J, Boddy AV, Wheatley K, Pignon JP, De Vathaire F, Le Deley MC, Le Teuff G
Publicatie
Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8(+) lymphocytes in primary sarcomas is subtype dependent
Oncotarget. 2017 Jul 7;8(41):71371-71384 PMID: 29050367
van Erp AEM, Versleijen-Jonkers YMH, Hillebrandt-Roeffen MHS, van Houdt L, Gorris MAJ, van Dam LS, Mentzel T, Weidema ME, Savci-Heijink CD, Desar IME, Merks HHM, van Noesel MM, Shipley J, van der Graaf WTA, Flucke UE, Meyer-Wentrup FAG